Pharmaceutical Company
FDA - rare and orphan disease issues;
Prescription drug coverage and payment policies;
Medical innovation issues;
H.R. 1231/S. 456 - Research to Accelerate Cures and Equity for Children Act;
Orphan Drug tax provisions in H.R. 1. Intellectual property and potential changes to the patent system, generally Orphan drug payments under Medicare Part A.
HCR - Health Issues CPT - Copyright/Patent/Trademark MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NVG, LLC
1640 Rhode Island Ave. NW, Suite 700, Washington, DC, 20036, US
ANDREA LARUE LISA GERMAN FOSTER PATRICIA GRIFFIN ANDREA LARUE ANDREA LARUE LISA GERMAN FOSTER